SIADH

Clinical trials for SIADH explained in plain language.

Never miss a new study

Get alerted when new SIADH trials appear

Sign up with your email to follow new studies for SIADH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Diabetes drug shows promise for dangerous low sodium condition

Disease control Recruiting now

This study tests whether the diabetes drug empagliflozin (Jardiance) can safely raise low sodium levels in people with certain conditions like SIADH, liver failure, or kidney failure. About 172 adults with chronic low sodium will receive either the drug or a placebo for up to 30 …

Matched conditions: SIADH

Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control

Last updated Jun 27, 2026 07:57 UTC

SIADH

Get alerted when new SIADH trials appear

Diabetes drug shows promise for dangerous low sodium condition